The 2025 ICE-T Symposium highlighted expansion beyond BCMA to additional targets such as GPRC5D and FcRH5.
Anas Zayad, MD, PGY-1
Advertisement
Articles by Anas Zayad, MD, PGY-1
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
From Conference to Practice: Top 5 Takeaways From EHA 2026
2
Managing Toxicities Associated with ADCs in Metastatic TNBC
3
Givastomig Earns FDA Fast Track Designation in HER2-Negative Gastric Cancer
4
62 Integrating Dose Modifications for Effective Management of HR+, HER2– Early Breast Cancer With Abemaciclib
5